You are here

  • Home
  • Archive
  • Volume 100, Issue 7
  • A systematic review of as needed versus treat and extend ranibizumab or bevacizumab treatment regimens for neovascular age-related macular degeneration

Article metrics

Article menu
Download PDFPDF
Clinical science
A systematic review of as needed versus treat and extend ranibizumab or bevacizumab treatment regimens for neovascular age-related macular degeneration

 

Online download statistics by month:

Online download statistics by month: October 2015 to February 2023

AbstractFullPdf
Oct 2015117318
Nov 2015305111109
Dec 20151813047
Jan 20161594150
Feb 20161302735
Mar 2016901922
Apr 20161231330
May 20161341920
Jun 20166392362
Jul 20165452476
Aug 20162972848
Sep 20162352436
Oct 20162723332
Nov 20161392935
Dec 20161041221
Jan 20171461922
Feb 20171104513
Mar 20171175328
Apr 2017842418
May 20171013725
Jun 20171503217
Jul 20171422016
Aug 20171912718
Sep 20173142922
Oct 20174682323
Nov 20172633114
Dec 2017204387
Jan 20181713010
Feb 20182454014
Mar 2018139279
Apr 20182345830
May 2018189229
Jun 20181512910
Jul 20181833316
Aug 2018162329
Sep 20181203410
Oct 2018156239
Nov 20181482610
Dec 2018167219
Jan 2019135238
Feb 2019147187
Mar 20191731410
Apr 2019102167
May 20191082112
Jun 20192013414
Jul 20191572912
Aug 2019109258
Sep 2019109193
Oct 20191172413
Nov 2019178267
Dec 2019107204
Jan 2020117214
Feb 202099244
Mar 202094248
Apr 202089227
May 20201213311
Jun 202080209
Jul 2020177164
Aug 202081121
Sep 2020125142
Oct 20201221912
Nov 20208888
Dec 202012425
Jan 202110378
Feb 20219085
Mar 20216335
Apr 20216598
May 20213063
Jun 2021855
Jul 2021558
Aug 2021972
Sep 2021870
Oct 2021711011
Nov 20218753
Dec 202114832
Jan 20229460
Feb 20225522
Mar 202211272
Apr 202212074
May 202296106
Jun 202215264
Jul 20227765
Aug 2022124116
Sep 202297103
Oct 2022108126
Nov 202211563
Dec 2022143216
Jan 202386133
Feb 2023119137
Total1297018781306